Filler for removing host nucleic acid residues in biological tool enzyme through DNA binding protein Ssh7b and application of filler
By combining the DNA-binding protein Ssh7b and a new filler of streptavidin agarose gel, the problem of long and high workload of host nucleic acid residue removal in biological tool enzymes is solved, and the rapid and simple removal effect is achieved, improving the Product quality and cost-effectiveness.
Patent Information
- Application Number
- CN202411063107.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-05
- Publication Date
- 2024-12-03
Smart Images

Figure CN119056423A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the biological field, and particularly relates to a filler for removing host nucleic acid residues in a biological tool enzyme using a DNA binding protein Ssh7b and an application thereof. Background Art
[0002] Biological tool enzymes are often used in molecular diagnosis, raw materials for nucleic acid drugs, and quality control of protein drugs. These three scenarios require strict control of the residual host nucleic acids in the tool enzymes. Biological tool enzymes are produced by recombinant expression in prokaryotic or eukaryotic host cells. Although these complex production systems undergo rigorous purification processes, host cell nucleic acid fragments may still remain in the product. From the perspective of biological product safety and effectiveness requirements, nucleic acid residues are the top priority of various quality control standards. Because residual host cell nucleic acids are still potentially harmful, there are certain safety risks, which are mainly reflected in the potential risks of tumorigenicity, infectivity, immunogenicity, and mutagenicity.
[0003] In the work of removing host nucleic acid, the difficulty is that DNA carries a large amount of charge and is easy to combine with other biomacromolecules, thus generating aggregation (adsorption) and encapsulation, which makes it difficult to completely remove it. At present, the main methods for removing host nucleic acid from biological tool enzymes on the market are: the first method is ion exchange chromatography. DNA carries a large amount of negative charge and can be removed by adsorption by anion exchangers. However, this method has a large load and is time-consuming. The second method is the enzyme method. It is mainly human deoxyribonuclease I and universal nuclease. Human deoxyribonuclease I (deoxyribonuclease I, DNase1) is an acidic glycoprotein with endonuclease activity. The characteristic of DNase1 is that it has DNase activity and is mainly used to remove DNA from RNA. Universal nuclease can effectively degrade various forms of DNA and RNA, and has high activity on the phosphodiester bonds of single-stranded, double-stranded, linear, circular and supercoiled forms of DNA and RNA, producing 5'-phosphate nucleotides and 5'-phosphate oligonucleotides. Both are characterized by efficient removal of nucleic acid residues, no sequence requirements for nucleic acids, simple operation and short time consumption. However, the application scenarios are limited. If the substrate is nucleic acid, the residual nuclease will cause great trouble to subsequent experiments. Therefore, the enzymatic host removal method cannot be widely used.
[0004] Traditional methods have problems such as large workload, long time consumption, and limited application areas. Therefore, there is an urgent need to explore a method that is comparable to anion host removal, less time-consuming, and can remove host DNA residues in biological tool enzymes. Summary of the invention
[0005] Purpose of the invention: In order to solve the above technical problems, the present invention provides a filler for removing host nucleic acid residues in biological tool enzymes. The filler can solve the problems of cumbersome traditional host removal experiments and limited experimental environment, and also explores a new method for removing hosts with a new filler.
[0006] The invention also provides a preparation method and application of a filler for removing host nucleic acid residues in a biological tool enzyme.
[0007] Technical solution: In order to achieve the above-mentioned purpose, the present invention provides a filler for removing host nucleic acid residues in biological tool enzymes, wherein the filler comprises a DNA binding protein Ssh7b connected with an Avi-tag tag sequence, a biotin ligase and a streptavidin agarose gel.
[0008] Furthermore, the amino acid sequence of the protein Ssh7b is as shown in SEQ ID NO.1, the amino acid sequence of the biotin ligase is as shown in SEQ ID NO.2, and the Avi-tag sequence is GLNDIFEAQKIEWHE.
[0009] Preferably, the SEQ ID NO.1: MVTVKFKYKGEEKEVDTSKIKKVWRVGKMISFTYDEGGGKTGRGAVSEKDAPKELLQMLEKQKK;
[0010] Furthermore, the amino acid sequence of the DNA binding protein Ssh7b connected with the Avi-tag tag sequence is: GLNDIFEAQKIEWHEMVTVKFKYKGEEKEVDTSKIKKVWRVGKMISFTYDEGGGKTGRGAVSEKDAPKELLQMLEKQKK, and the gene encoded by it is shown in SEQ ID NO.4.
[0011] The SEQ ID NO.2: MKDNTVPLKLIALLANGEFHSGEQLGETLGMSRAAINKHI QTLRDWGVDVFTVPGKGYSLPEPIQLLNAKQILGQLDGGSVAVLPVIDSTNQYLLDRIGELKSGDACIAEYQQAGRGRRGRKWFSPFGANLYLSMFWRLEQGPAAAIGLSLVIGIVMAEVLRKLGADKVRVKWPNDLYLQD RKLAGILVELTGKTGDAAQIVIGAGINMAMRRVEESVVNQGWITLQEAGINLDRNTLAAMLIRELRAALELFEQEGLAPYLSRWEKLDNFINRPVKLIIGDKEIFGISRGIDKQGALLLEQDGIIKPWMGGEISLRSAEK.
[0012] Furthermore, the gene encoding biotin ligase is shown in SEQ ID NO.3.
[0013] The method for preparing the filler for removing host nucleic acid residues in the biological tool enzyme of the present invention comprises the following steps:
[0014] (1) Avi-tag was added to the amino acid sequence of DNA binding protein Ssh7b and constructed into the PET28a vector together with biotin ligase;
[0015] (2) co-expressing the amino acid vector plasmid containing the target protein obtained in step (1) and the biotin ligase vector plasmid in a DE3 competent medium, activating and inducing, and centrifuging to remove the supernatant to obtain bacterial sludge;
[0016] (3) The protein supernatant obtained by centrifugation after the bacterial sludge is crushed is passed through an affinity chromatography heparin column and an ion column to obtain a pure target protein, which is then concentrated and dialyzed;
[0017] (4) The concentrated protein is incubated with streptavidin agarose gel to form a new chromatography filler.
[0018] Furthermore, the process of purifying the protein in step (3) is as follows: first, the collected protein supernatant is passed through a heparin column, then the collected sample after heparin is passed through an SP column, the collected sample after passing through the SP column is passed through a Q column, the sample after passing through the Q column is added to a dialysis bag and then placed in polyethylene glycol for concentration, and the concentrated sample is placed in a low-salt buffer for dialyzation.
[0019] Furthermore, the molecular weight cut-off of the dialysis bag is 3-5 KDa, and the polyethylene glycol is polyethylene glycol 20000.
[0020] Preferably, the dialysis bag has a molecular weight cut-off of 3 KDa.
[0021] Furthermore, in step (4), the agarose gel is first taken and the supernatant is removed, the agarose gel is washed, the protein solution is diluted and placed in a streptavidin agarose gel for incubation overnight, a washing buffer is added to the agarose gel, the agarose gel is resuspended, the supernatant is taken by centrifugation, and finally the precipitate is taken, which is the synthesized new chromatography filler.
[0022] Furthermore, the incubation temperature is 0-4°C and the duration is 16-20 hours.
[0023] Among them, the filler of the present invention is used in removing host nucleic acid residues in biological tool enzymes.
[0024] Furthermore, the application process is: flowing the RNase inhibitor solution through the chromatography filler and receiving the flow-through liquid at the same time, and detecting the host Ct value with a qPCR instrument.
[0025] Furthermore, the qPCR primers are: 23S rRNA-F: 5'GTCTGGAAAGGCGCGCGA 3'; 23S rRNA-R: 5'GTGTCCCGCCCTACTCA3'.
[0026] The present invention adopts a new filler prepared by combining DNA binding protein with streptavidin, and the new filler can specifically bind to the host nucleic acid in the flow-through solution. The implementation solution only needs to flow through the filler, and the flow-through liquid can be collected to achieve the purpose of removing the host. The existing Q filler needs to go through a balanced filler, sample loading, single-step or even multi-step cleaning, elution, protein dispensing, and finally the protein solution can be collected according to the gel map in order to remove the host. It takes multiple steps to reduce the host content of the implementation solution. The new filler prepared by the present invention can greatly reduce the time cost, is simple and convenient to operate, avoids multi-step operation, reduces the cost of consumables such as materials, reagents, and instruments required for enterprise experiments, and increases the profit of the product. It is of great significance in the quality control of biological tool enzymes, and is suitable for efficient, rapid and cost-effective protein purification processes. At present, the prior art does not use a method for removing the host nucleic acid residues of biological tool enzymes by combining DNA binding protein with streptavidin to prepare a purification filler. The present invention combines the biotinylated DNA binding protein Ssh7b with streptavidin agarose gel to form a new chromatography medium, so that the double-stranded DNA is combined with the chromatography medium, and the target protein directly penetrates, and then the purified liquid is collected, thereby achieving the purpose of removing host DNA and host protein, further reducing the residual amount of host DNA in the finished biological tool enzyme, and improving the quality of the tool enzyme product.
[0027] The present invention specifically binds biotinylated proteins to streptavidin for the first time, and the DNA binding protein is biotinylated so that it can be firmly bound to streptavidin, and Ssh7b will not fall off easily, thereby preparing a new filler. When RI protein (RNase inhibitor) flows through the new filler prepared by the present invention, Ssh7b exerts its function and can bind to DNA in the RI protein solution, and the new filler does not bind to the RI protein, and the host DNA content of the solution after the flow can be reduced.
[0028] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages:
[0029] The biotinylated DNA binding protein Ssh7b is combined with streptavidin agarose gel to form a new chromatography medium for use in the purification of biological tool enzymes. The flow-through mode is adopted, that is, the target protein flows through when the sample is loaded, and the host DNA is adsorbed on the chromatography column to achieve the purpose of purification. The operation is simple and fast, saving a lot of time cost, effectively reducing host DNA, breaking through the quality bottleneck of tool enzymes, and improving product quality standards. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 Schematic diagram of the preparation principle and application of the new Ssh7b filler;
[0031] Figure 2 Construction of an expression vector for the biotin ligase BirA inserted into the Pet28a multiple cloning site;
[0032] Figure 3 Construction of expression vector for insertion of Ssh7b-Avi tag into PET28a multiple cloning site;
[0033] Figure 4 The gel image confirms the new filler of Ssh7b;
[0034] Figure 5 The effect of 2M NaCl on Ssh7 binding to SA during the preparation of the new filler;
[0035] Figure 6 Flow chart of the new filler and Q filler for the example RNase inhibitor;
[0036] Figure 7 The graphs are as follows: the sample after RI passed through the nickel column passed through the Q matrix (filler) and the new filler respectively; the graphs are as follows: the sample after RI passed through the Q column passed through the Q filler and the new filler respectively;
[0037] Figure 8 This is the amplification curve of the sample after the RI nickel column in Example 1, the first time through the Q filler and the new filler;
[0038] Fig. 9This is the amplification curve of the sample after the RIQ column in the embodiment, the first pass through the Q filler and the new filler;
[0039] Fig.10 This is the amplification curve of the sample after the RI nickel column in Example 1, the second pass through the Q filler and the new filler;
[0040] Fig.11 This is the amplification curve of the sample after the RIQ column in the embodiment, the second pass through the Q filler and the new filler;
[0041] Fig.12 This is the amplification curve of the sample after the RI nickel column in Example 1, the third time through the Q filler and the new filler;
[0042] Fig.13 This is the amplification curve of the sample after the RIQ column in Example 1, the third pass through Q filler and the new filler. DETAILED DESCRIPTION
[0043] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.
[0044] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources. Experimental methods without specific conditions specified in the examples are usually carried out under conventional conditions or under conditions recommended by the manufacturer.
[0045] The English letters of the present invention are described as follows:
[0046] Flow: flow-through; Wash: washing solution; Elute: elution solution; SA: streptavidin.
[0047] Drugs and reagents:
[0048] Low salt buffer A: 20 mM NaPO 4 , 0.1 mM EDTA, 5% glycerol, pH 7.0 @ 25 °C;
[0049] High salt buffer B: 20 mM NaPO 4 , 0.1 mM EDTA, 5% glycerol, 1 M NaCl pH 7.0 @ 25 °C;
[0050] Heparin affinity chromatography medium: Zhongke Senhui Microsphere Technology (Suzhou) Co., Ltd., catalog number: 16-0020-06;
[0051] SP packing SP Sanarose HP: Xiamen Sanji Technology Co., Ltd., item number: NSH00100;
[0052] Capto Q ion exchange chromatography medium: Cytiva, batch number: 17531610;
[0053] Nickel filler Ni-IDA Sanarose 6FF: Xiamen Sanji Technology Co., Ltd., catalog number: NIA01000;
[0054] Prepacked plastic empty column (ion exchange column, PrePack CM Q Purose 6HP): Jiaxing Qianchun Biotechnology Co., Ltd., catalog number: ZA20304-16;
[0055] The present invention adds nickel filler, heparin, Q filler and SP filler into the empty column to form nickel column, heparin column, Q column and SP column for experiment, wherein the anion column is Q column and the cation column is SP column.
[0056] Recombinant protein of ribonuclease inhibitor (RI): recombinant mouse RNase inhibitor, Jiangsu Best Biotechnology Co., Ltd., catalog number: EG20002S;
[0057] 4×SDS protein loading: Jiangsu Baishimei Biological Co., Ltd., batch number: 3234803241.
[0058] Example 1
[0059] like Figure 1 As shown, a method for removing host nucleic acid specifically comprises the following steps:
[0060] Step 1: Construct vector
[0061] The protein sequence of biotin ligase (GenBank: AAN88945.1) was searched on the NCBI website. After codon optimization, the gene sequence (SEQ ID NO.3) was synthesized by a gene synthesis company and inserted into the Pet28a multiple cloning site to construct an expression vector (between the restriction sites NcoI and EcoRI). The expression vector model is as follows: Figure 2 Similarly, the protein sequences of Avi-tag (GenBank: QBQ88493.1) and Ssh7b (GenBank: BAA28275.1) were obtained from the NCBI website. After codon optimization, the Avi tag-ssh7b gene sequence (SEQ ID NO.4) was sent to a gene company for synthesis and inserted into the PET28a multiple cloning site to construct an expression vector (between the restriction sites NcoI and EcoRI). The expression vector model is as follows Figure 3 shown.
[0062] Step 2: Prepare bacterial mud
[0063] 1. Plate transformation steps:
[0064] Take 100ng Ssh7b plasmid and 100ng biological ligase plasmid, co-transform and add to 50μL competent BL21 (DE3), and place on ice for 30min; heat shock at 42℃ for 1min, and place on ice for 5min; add 500μL antibiotic-free culture medium, and activate at 37℃, 200rpm for 1h; take 100μL activation solution and apply to kanamycin resistance plate, invert and place at 37℃ for about 16h;
[0065] 2. Vial activation stage:
[0066] Select about 50 monoclonal colonies and inoculate them into 200 mL of culture medium, activate them in a 1000 mL shake flask, grow them for 3.5 h at 37°C and 200 rpm, and measure the OD 600 When UV is about 0.8, proceed to the next step;
[0067] 3. Large bottle expansion stage:
[0068] Prepare 3 bottles of 500 mL culture medium, inoculate each bottle with 50 mL activation solution (10% inoculation amount), expand the culture in a 2000 mL shake flask, 37°C, 200 rpm, grow for 3.5 hours, and measure OD 600 UV is around 0.8;
[0069] 4. Large bottle induction stage:
[0070] Add IPTG to each bottle at a final concentration of 1mM for induction, 30℃, 200rpm, and end the fermentation after 4h of induction. Collect the bacteria; centrifuge to collect the bacteria; fermentation volume is 1.5L; measure OD 600 UV 1.83; 9800g, 4℃ centrifugation for 10 min to collect bacteria; discard the supernatant to obtain bacterial sludge, weighing 9.6g.
[0071] 5. Sample pretreatment:
[0072] Take 6.5g of fermented bacterial sludge; add lysis solution (20mM NaPO 4 (pH7.0@25℃), 0.1mM EDTA, 5% glycerol,) 65mL, then add 100mM PMSF 65μL of protease inhibitor, 1000×PI 65μL to resuspend; then high pressure 850bar, crush for 10min until the bacterial solution is clear. Finally, centrifuge at 25000g, 4℃ for 30min, take the supernatant, and obtain the crude enzyme solution sample.
[0073] Step 3: Protein purification
[0074] A three-step purification scheme is used to purify the target protein. Heparin HP filler is combined with cationic SP filler for purification; finally, in order to reduce the host content of the protein itself, it is passed through anionic Q filler and the Flow is collected. The specific steps are as follows:
[0075] 1. The supernatant of crude enzyme solution is passed through a heparin column
[0076] (1) Balance: Use low salt buffer A (20 mM NaPO 4 (pH 7.0 @ 25 ° C), 0.1 mM EDTA, 5% glycerol) for 3 column volumes until the conductivity and UV280 are stable, and the flow rate is set to 2 ml / min;
[0077] (2) Sampling: 65 ml of the crude enzyme solution obtained by the above sample pretreatment is loaded through the sample pump pipeline, and the flow rate is set to 1 ml / min;
[0078] (3) Cleaning: Run 3CV with low-salt buffer. When the conductivity and UV280 baselines are stable, the cleaning is completed and the flow rate is set to 1 ml / min.
[0079] (4) Elution: Use pipelines A and B. The buffer of pipeline A1 is low-salt buffer A, and the buffer of pipeline B is high-salt buffer B (20 mM NaPO 4 (pH 7.0 @ 25 ° C), 0.1 mM EDTA, 5% glycerol, 1 M NaCl), set the flow rate to 2 ml / min, 0%-100% high salt buffer eluent, and elute for 10 column volumes.
[0080] (5) Collection: Record the number of each tube, record the collection volume, collect the Flow, Wash, Elute after the heparin column, add protein 4×SDS protein loading to run SDS-PAGE, observe whether there is the target band of Ssh7b, collect several tubes of Elute with the target band and mix them together for the next column purification.
[0081] 2. Collect the sample after heparinization and pass it through SP column
[0082] (1) Balance: same as heparin column;
[0083] (2) Sample loading: The sample conductivity of the ion packing should be kept within 10 mS / cm. The heparinized sample should be washed with a low-salt buffer (20 mM NaPO 4 (pH 7.0@25°C), 0.1 mM EDTA, 5% glycerol) will be diluted to the corresponding conductivity value.
[0084] (3) Cleaning: Same as heparin column;
[0085] (4) Elution: same as heparin column;
[0086] (5) Collection: same as heparin column;
[0087] 3. Collect the samples after passing through the SP column and pass them through the Q column to reduce the host residues of the bound protein itself. At the same time, the Q column can also improve the protein purity.
[0088] The process of protein purification by the Q column is as follows:
[0089] (1) Balance: Same as SP column;
[0090] (2) Sample loading: The sample conductivity of the ion packing material should be kept within 10 mS / cm. Dilute the sample after SP with low-salt buffer to the corresponding conductivity value. Collect the flow for future use.
[0091] 4. Collect the sample after passing through the Q column and place it in polyethylene glycol 20000 to concentrate and increase the concentration. The process is as follows:
[0092] Prepare a beaker, wash it, fill it with an appropriate amount of distilled water, and heat it to a slight heat. Cut a 3Kda molecular weight cutoff dialysis bag of appropriate length according to the sample volume, put on disposable gloves and soak the cut dialysis bag in water for 10 minutes. Clamp one end of the sealing film with a clamp, pour Watsons water into the dialysis bag, and there is no leakage in the dialysis bag. After confirming the sealing of the dialysis bag, pour out the solution, use a pipette to carefully absorb the protein sample and add it to the dialysis bag. Lay it flat on polyethylene glycol 20000 for concentration, remove the wet polyethylene glycol 20000 on the dialysis bag every half an hour, replace it with new polyethylene glycol 20000, and concentrate for about 4 hours.
[0093] 5. The concentrated sample is dialyzed in a low-salt buffer.
[0094] After the concentration, the sample was taken out and placed in a 50 ml centrifuge tube without zymogen. A dialysis bag of appropriate length (dialysis bag molecular weight cutoff is 3 KDa) was reassembled according to the above operation. The sample in the tube was then sucked into a new dialysis bag. The dialysis bag was placed horizontally in a low-salt dialysis solution (20 mM NaPO 4 (pH 7.0@25°C), 0.1 mM EDTA, 5% glycerol), turn on the magnetic stirrer, collect the dialysate after dialysis for 2 hours, and obtain the biotinylated Ssh7b protein.
[0095] Step 4: Preparation of new filler:
[0096] The biotinylated Ssh7b protein prepared in step 3 was combined with streptavidin agarose gel to prepare a new filler. All preparation steps used a filter cartridge box pipette tip and were performed on ice. The specific steps are as follows:
[0097] (1) Quantitative marking: Take a 15 ml sterilized centrifuge tube, add 600 ul of enzyme-free water, and mark the location of the 600 ul water; after marking, use a gun to remove the water. Take out Streptavidin Agarose (SA, Beyotime, Cat No. P2159-5ml) from the -20°C refrigerator and dissolve it on ice.
[0098] (2) Take agarose gel and remove the supernatant: Gently resuspend the streptavidin agarose gel to form a uniform gel suspension, take 600ul of Beyotime's streptavidin agarose gel (excluding the solution), place it in a 15ml centrifuge tube for later use. Centrifuge at 1000×g at 4℃ for 1min, and discard the supernatant after centrifugation.
[0099] (3) Washing agarose gel: Add TBS (10 mM Tris, pH 7.4) to a final volume of about 4 ml, gently resuspend the streptavidin agarose gel, centrifuge at 1000 × g at 4°C for 5 min, carefully remove the supernatant without aspirating the gel, complete one washing step, and then wash twice more.
[0100] (4) Protein adsorption: Take 2.4 mg of biotinylated Ssh7b protein, add 2 ml of Washing Buffer II (10 mM Tris (pH 7.4), 0.05% Tween-20, pH 7.4) of equal volume to dilute, mix well and take 100 ul as the pre-incubation control gel. Add the remaining samples to the agarose gel in the above step, resuspend and place on a rotating mixer, incubate at 4°C for 16 hours overnight, centrifuge at 1000g at 4°C for 5 minutes the next day, take 100 ul of the supernatant and apply gel to ensure that the amount of DNA binding protein adsorption is overloaded.
[0101] (5) Washing: Washing Buffer I (10mM Tris (pH7.4), 0.05% Tween-20, 1M NaCl, pH7.4) contains 1M NaCl. High salt can remove the content of the host in the newly prepared filler. Take 4ml of Washing Buffer I and add it to the agarose gel. Gently resuspend the agarose gel. Centrifuge at 1000g, 4℃ for 5 minutes, remove the supernatant, and take the precipitate, which is the newly synthesized chromatography filler (ssh7b filler). Wash the new filler twice.
[0102] Finally, wash once more with 4 ml of Washing Buffer II, centrifuge, and take 3.9 ml of supernatant. After each wash, take 100 ul of supernatant and apply gel. Use the remaining 100 ul of the new filler to mix with Washing Buffer II, and take the remaining precipitate of the new filler and apply gel to confirm that the biotinylated DNA binding protein is bound to the streptavidin gel. Figure 4 As shown in the protein gel, lanes 1 and 8 are protein markers; lane 2 is Ssh7b protein, that is, the solution before Ssh7b and SA are incubated; lane 3 is the supernatant after Ssh7b and SA are incubated; lanes 4, 5, and 6 are the supernatants after the newly prepared filler is washed with Washing Buffer; and lane 7 is the newly prepared filler. It can be seen from lane 3 that there is still a large amount of Ssh7b protein in the supernatant after Ssh7b and SA are incubated, indicating that the protein binding amount has reached saturation. It can be seen from lane 3 that there is no target protein in the supernatant after the newly prepared filler is washed with Washing Buffer, indicating that Ssh7b protein is not easy to fall off from SA. It can be seen from lane 7 that Ssh7b has specifically bound to SA, indicating that Ssh7b is a biotinylated protein.
[0103] Example 2
[0104] The method of Example 1 was used, except that in step 4, 1M NaCl in the washing process was replaced with 2M NaCl in the preparation of the new filler, and the other processes remained unchanged. Figure 5 As shown, lane 1 is the newly prepared filler, lane 2 is the protein marker, and lane 3 is the supernatant after incubation of Ssh7b and SA. It can be seen from lane 1 that Ssh7b cannot bind to SA, indicating that 2M NaCl, i.e., high salt solution, will affect the binding of DNA binding protein to streptavidin agarose gel.
[0105] Example 3
[0106] RI flows through new filler and Q filler to detect host Ct value
[0107] Protein RNase inhibitor (RI) was used to compare the ability of newly prepared fillers and anionic fillers to remove host. The reasons for using RI are: first, RI has no ability to degrade, cut, or eliminate nucleic acid fragments; second, RI has a high protein yield; and third, the purification process contains anionic columns to remove host and impurities.
[0108] like Figure 6As shown, RI first passes through the nickel column, and a small portion of the sample after the nickel column is passed through 45ul of the newly prepared filler and 45ul of the Q filler in Example 1 to determine the ability of the two fillers to remove the host under high host conditions. The remaining sample after the nickel column passes through the Q column, and a small portion of the sample after the Q column is passed through 45ul of the newly prepared filler and 45ul of the Q filler to determine the ability of the two fillers to remove the host under low host conditions.
[0109] The specific operations are as follows:
[0110] (1) RI new filler: Take a 1.5ml high temperature sterilized EP tube, add 45ul enzyme-free raw water, mark the position of 45ul water, and remove the water with a gun after marking.
[0111] (2) The newly prepared ssh7b filler precipitate filler in Example 1 was divided into 6 portions, each portion containing 45u1 filler, and 3 parallel samples were made to reduce errors. Excess Washing Buffer II was removed by centrifugation, and 150ug and 300ug of the sample after RI passed through the nickel column and 150ug and 300ug of the sample after RI passed through the Q column were taken into 1.5ml EP tubes respectively; 45ul of the newly prepared ssh7b filler was added respectively, and the mixture was incubated on a shaker at 4℃, 2h, 230rpm; and the supernatant was collected by centrifugation at 1000g, 4℃ for 4min. Two different ratios of sample to filler were designed, sample: filler = 1:2 (150ug: 45u1, w / v, ug / ul), sample: filler = 2:1 (300ug: 45u1, w / v, ug / ul), so as to eliminate the influence of different sample to filler ratios on host removal.
[0112] (3) RI over Q filler: Take a 1.5 ml high temperature sterilized EP tube, add 45 ul enzyme-free raw water, mark the position of the 45 ul water, and remove the water with a gun after marking.
[0113] (4) Take 45ul of 6 portions of Q filler (anion filler), centrifuge and remove the supernatant. Add 1ml of RI low-salt buffer, vortex gently to mix, then centrifuge at 1000×g at 4℃ for 1min, wash twice to completely remove 20% ethanol in the filler. Take 150ug and 300ug of the sample after RI passed through the nickel column and 150ug and 300ug of the sample after RI passed through the Q column and pass through 45ul of Q filler. Two different ratios of sample and filler are designed, sample: filler = 1:2 (150ug: 45u1, w / v, ug / ul), sample: filler = 2:1 (300ug: 45u1, w / v, ug / ul). Incubate on a shaker for 2h, 4℃, 230rpm; centrifuge at 1000g, 4℃ for 1min, and remove the supernatant. Add RI low-salt buffer (20mMNaH 2 PO 4-NaOH, 0.1mM EDTA, 1mM DTT, 5% glycerol (pH6.0@25℃)) 1ml, centrifuge and remove the supernatant. Then add 40% RI high salt buffer (20mM NaH 2 PO 4 -NaOH, 1M NaCl, 0.1mM EDTA, 1mM DTT, 5% glycerol (pH6.0@25℃)) 150ul, 60% RI low salt buffer 225ul elution incubation for 0.5h. After elution and incubation, centrifuge at 1000g, 4℃, 4min, and collect the supernatant.
[0114] (5) The supernatant collected in steps (2) and (4) was subjected to fluorescence quantitative PCR detection. The results are shown in Table 1:
[0115] Table 1 Fluorescence quantitative PCR detection results
[0116]
[0117]
[0118] According to the above table and attached Figures 7 to 13 It can be seen that. RI sample 150ug and filler 45u1, as a sample to filler ratio of 1:2; RI sample 300ug and filler 45u1, as a sample to filler ratio of 2:1. There is no significant difference in host removal with different sample to filler ratios. The newly prepared filler prepared by combining Ssh7b with streptavidin agarose gel has the ability to remove the host in the sample after RI passes through the nickel column in Example RI, that is, under the background of high background host content, but the difference is significant compared with the Q filler. In the sample after RI passes through the Q column in Example RI, that is, under the background of low background host content, the newly prepared filler has the ability to remove the host, and the effect is basically the same as that of the anionic Q filler. Therefore, the DNA binding protein Ssh7b has the ability to remove host nucleic acid residues in biological tool enzymes. In summary, the present invention can achieve the purpose of removing host DNA and host proteins through a one-step method, that is, the RI protein flow passes through the new filler, so that the residual host DNA of the finished biological tool enzyme is further reduced, the time cost is greatly reduced, multi-step operation is avoided, and the quality of the tool enzyme product is improved.
Claims
1. A filler for removing host nucleic acid residues in biological tool enzymes, characterized in that: The filler comprises a DNA binding protein Ssh7b connected with an Avi-tag label sequence, a biotin ligase and a streptavidin agarose gel.
2. The filler for removing host nucleic acid residues in biological tool enzymes according to claim 1, characterized in that: The amino acid sequence of the protein Ssh7b is shown in SEQ ID NO.1, the amino acid sequence of the biotin ligase is shown in SEQ ID NO.2, and the Avi-tag sequence is GLNDIFEAQKIEWHE.
3. A method for preparing a filler for removing host nucleic acid residues in a biological tool enzyme according to claim 1, characterized in that: The steps include: (1) An Avi-tag tag was added to the amino acid sequence of the DNA binding protein Ssh7b, and its encoding gene and the biotin ligase encoding gene were constructed into the PET28a vector respectively; (2) co-expressing the target protein encoding gene vector plasmid obtained in step (1) and the biotin ligase encoding gene vector plasmid in competent Escherichia coli, activating and inducing, and centrifuging to remove the supernatant to obtain bacterial sludge; (3) The protein supernatant obtained by centrifugation after the bacterial sludge is crushed is passed through an affinity chromatography heparin column and an ion column to obtain a pure target protein, which is then concentrated and dialyzed; (4) The concentrated protein is incubated with streptavidin agarose gel to form a new chromatography filler.
4. The method for preparing a filler for removing host nucleic acid residues in a biological tool enzyme according to claim 3, characterized in that: The process of purifying the protein in step (3) is as follows: first, the collected protein supernatant is passed through a heparin column, then the sample after the heparin is collected is passed through an SP column, the sample after the SP column is collected is passed through a Q column, the sample after the Q column is added to a dialysis bag and then placed in polyethylene glycol for concentration, and the concentrated sample is placed in a low-salt buffer for dialyzation.
5. The method for preparing a filler for removing host nucleic acid residues in a biological tool enzyme according to claim 4, characterized in that: The molecular weight cut-off of the dialysis bag is 3-5 KDa, and the polyethylene glycol is polyethylene glycol 20000.
6. The method for preparing a filler for removing host nucleic acid residues in a biological tool enzyme according to claim 3, characterized in that: The step (4) first takes streptavidin agarose gel and removes the supernatant, washes the agarose gel, dilutes the protein solution and places it in the streptavidin agarose gel for incubation overnight, takes a washing buffer and adds it to the agarose gel, resuspends the agarose gel, centrifuges and removes the supernatant, and finally takes the precipitate to obtain the synthesized new chromatography filler.
7. The method for preparing a filler for removing host nucleic acid residues in a biological tool enzyme according to claim 6, characterized in that: In step (4), the incubation temperature is 0-4°C and the incubation time is 16-20 hours.
8. Use of the filler according to claim 1 in removing host nucleic acid residues in biological tool enzymes.
9. The use according to claim 8, characterized in that: The application process is: let the RNase inhibitor solution flow through the filler and receive the flow-through liquid at the same time, and then detect the host Ct value with a qPCR instrument.
10. The use according to claim 9, characterized in that: The qPCR primers are: 23S rRNA-F: 5'GTCTGGAAAGGCGCGCGA3'; 23S rRNA-R: 5'GTGTCCCGCCCTACTCA3'.
Citation Information
Cited By
Preparation method and application of single-chain binding protein
CN119306806A
